- Asundexian versus Apixaban in Patients with Atrial Fibrillation. The New England Journal of Medicine (NEJM) 2025. OCEANIC-AF Steering Committee and Investigators: From Norway John Munkhaugen, Drammen sykehus, MED/NORCOR.
- Statin adherence in coronary outpatients: The relationship between a novel blood test and pharmacy registry data. Atherosclerosis 2025
- Hvordan kan vi hjelpe hjertepasienten med livsstilsendringer i 2024? Hjerteforum N° 1/ 2025/ vol 38 (s. 108-112). Fagartikkel.
- The effects of cognitive behavioral therapy for insomnia in patients with cardiovascular disease: a systematic review and meta-analysis. Journal of Clinical Sleep Medicine 2025
- Low-Density Lipoprotein Cholesterol Increases Significantly During Brief Discontinuation of Atorvastatin and Correlates With Metabolite Half-Lives. Pharmacology Research & Perspectives 2025
- More musculoskeletal disorders and poor pain management in patients with familial hypercholesterolemia and self-perceived side effects to cholesterol-lowering treatment. Posterpresentasjon. Internasjonal konferanse ESC Preventive Cardiology 2025, Milan Italy.
- Potential benefits of group cognitive-behavioural therapy for insomnia in patients with coronary heart disease versus usual care: an early economic evaluation. Posterpresentasjon. Internasjonal konferanse ESC Preventive Cardiology 2025, Milan Italy.
- Motivational smoking cessation counselling with proactive referral to community-based follow-up after hospitalisation for vascular disease: a pragmatic, randomised trial. Posterpresentasjon. Internasjonal konferanse ESC Preventive Cardiology 2025, Milan Italy.
- Clinical and psychosocial predictors of long-term smoking cessation in patients with atherosclerotic vascular disease: a pre-specified analysis of two randomised trials. Posterpresentasjon. Internasjonal konferanse ESC Preventive Cardiology 2025, Milan Italy.
